HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India.

Abstract
Quinone oxidoreductases (NAD(P)H): quinone oxidoreductase 1 (NQO1) and NRH: quinone oxidoreductase 2 (NQO2) are an antioxidant enzyme, important in the detoxification of environmental carcinogens. Methylene-tetra-hydrofolate reductase (MTHFR), plays a role in folate metabolism and may have oncogenic role through disruption of normal DNA methylation pattern, synthesis, and impaired DNA repair. In a case-control study, genotyping was done in 195 PCa and 250 age matched unrelated healthy controls of similar ethnicity to determine variants in NQO1 exon 4 (C > T, rs4986998), exon 6 (C > T, rs1800566), NQO2 -3423 (G > A, rs2070999) and MTHFR exon 4 (C > T, rs1801133) by PCR-RFLP methods. Heterozygous genotype CT and variant allele career genotype (CT + TT) of NQO1 exon 4 showed increased risk of PCa (OR = 2.06, p = 0.033; OR = 2.02, p = 0.027). Variant allele T also revealed increased risk (OR = 1.87, p = 0.029). Similarly variant genotype TT (OR = 2.71, p = 0.009), combined genotype (CT + TT) (OR = 1.59, p = 0.019) and T allele (OR = 1.63, p = 0.002) of NQO1 exon 6 demonstrated significant risk for PCa. Diplotypes of NQO1 (exon 4 and 6), C-T (OR = 1.56, Pc = 0.007) and T-T (OR = 0.011, Pc = 3.86) was associated with an increased risk for PCa. NQO2 and MTHFR did not show any risk with PCa. Our results strongly support that common sequence variants and diplotypes of NQO1 exon 4 and 6 genes may have role in PCa risk in the North Indian population, indicating the importance of genes involved in metabolism with respect to PCa risk. Additional studies on larger populations are needed to clarify the role of variation in these genes in PCa carcinogenesis.
AuthorsRaju K Mandal, Kamran Nissar, Rama D Mittal
JournalMolecular biology reports (Mol Biol Rep) Vol. 39 Issue 12 Pg. 11145-52 (Dec 2012) ISSN: 1573-4978 [Electronic] Netherlands
PMID23054000 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MTHFR protein, human
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • NRH - quinone oxidoreductase2
  • Quinone Reductases
Topics
  • Aged
  • Bone Neoplasms (secondary)
  • Case-Control Studies
  • Demography
  • Environment
  • Epistasis, Genetic
  • Exons (genetics)
  • Gene Frequency (genetics)
  • Genetic Predisposition to Disease
  • Humans
  • India
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) (genetics, metabolism)
  • NAD(P)H Dehydrogenase (Quinone) (genetics, metabolism)
  • Neoplasm Grading
  • Odds Ratio
  • Polymorphism, Single Nucleotide (genetics)
  • Prostatic Neoplasms (enzymology, genetics, pathology)
  • Quinone Reductases (genetics)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: